Pharmaceutical Technology

MARCH 22, 2024

Download our free, comprehensive list of the leading companies within the pharmaceutical drug delivery market.

Drug Delivery 130

Drug Delivery Marketing Drugs 130

Drug Patent Watch

NOVEMBER 18, 2024

The pharmaceutical industry is undergoing a significant shift, with emerging markets offering the next growth opportunity. This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs.

Generic Drugs 59

Generic Drugs Marketing Development Drugs 59

Drug Patent Watch

OCTOBER 21, 2024

The filing of drug patents in emerging markets is a critical aspect of this protection, as it ensures that companies can recoup their investments and… Source The pharmaceutical industry is a significant contributor to the global economy, with a substantial portion of its production costs incurred during the development stage.

Marketing 94

Marketing Drugs Production Development 94

Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. This article will delve into the role of China in the global generic drug API market, exploring its market share… Source

Generic Drugs 102

Generic Drugs Marketing Drugs Production 102

Pharmaceutical Technology

AUGUST 20, 2024

The top 20 biopharmaceutical companies demonstrated resilience during the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve.

Marketing 263

Marketing Drugs 263

World of DTC Marketing

DECEMBER 3, 2020

Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. The disconnect between consumers and prescription drug marketing has grown quite a bit. What about marketing to doctors? The other issue is a payment to physicians.

Marketing 181

Marketing Drugs Doctors Doctor 181

Drug Patent Watch

SEPTEMBER 23, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the expiration of patents on branded drugs and the increasing demand for affordable healthcare solutions. However, the industry faces several challenges, including commoditization, regulatory hurdles, and intense competition.

Generic Drugs 88

Generic Drugs Marketing Drugs Branding 88

World of DTC Marketing

AUGUST 10, 2022

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. However, DTC marketing is different, much different. So what’s the opportunity for DTC marketers?

Marketing 252

Marketing Production Drugs Doctors 252

Pharmaceutical Technology

SEPTEMBER 27, 2024

The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 monoclonal antibody, Dupixent, for the US market.

FDA Approval 162

FDA Approval Marketing Antibody Drugs 162

World of DTC Marketing

JULY 21, 2021

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.

Marketing 285

Marketing Doctors Doctor Drugs 285

Pharmaceutical Technology

NOVEMBER 6, 2024

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts by the US Federal Reserve in September 2024.

Marketing 263

Marketing Drugs 263

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 14, 2024

The Subject Expert Committee (SEC), which advises the national drug regulator on matters related to approval of new drugs and medical devices and clinical trials, has recommended grant of market authorisation for Telangana-based MSN Laboratories for sleep disorder drug Pitolisant tablets.

Drugs 141

Drugs Clinical Trials Clinical Trials Branding 141

Pharmaceutical Technology

OCTOBER 25, 2023

Experts discuss the key trends in quality improvements and API reshoring for the generic drugs market at CpHI Europe.

Generic Drugs 147

Generic Drugs Marketing Drugs 147

Bio Pharma Dive

JULY 16, 2024

The well-funded startup says drugs AbbVie abandoned last year could form a combination regimen with “superior efficacy” to Vertex’s market-leading medicines.

Drugs 278

Drugs Medicine Marketing 278

Drug Patent Watch

JULY 25, 2024

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the crisis. As the world continues to recover…

Generic Drugs 96

Generic Drugs Marketing Drugs 96

Pharmaceutical Technology

JANUARY 23, 2023

As such, the SLE and LN marketplace is dominated by generics, and GSK’s Benlysta and AstraZeneca’s Saphnelo are the only drugs that have gained marketing approval specifically for SLE in more than 50 years. In previous years, Benlysta has managed to grow the lupus market in terms of value, having generated approximately $492.9m

Marketing 278

Marketing Production Drugs Trials 278

Pharmaceutical Technology

NOVEMBER 1, 2024

The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing Jazz’s challenge over market exclusivity for its own drug.

Drugs 162

Drugs Marketing 162

Bio Pharma Dive

MAY 3, 2024

The company said data for its Wegovy competitor was promising enough to move the drug into late-stage testing, triggering a stock jump that added billions to Amgen’s market value.

Drugs 282

Drugs Marketing 282

Pharmaceutical Technology

DECEMBER 5, 2023

Professor Timothy Mackey talks about the recent reports of fraudulent Ozempic pens and the challenges in chasing drug counterfeiters.

Drugs 278

Drugs Marketing 278

Fierce Pharma

SEPTEMBER 25, 2024

Pfizer will voluntarily pull its sickle cell disease drug Oxbryta from all markets worldwide, a major blow to a $5.4 Pfizer will voluntarily pull its sickle cell disease drug Oxbryta from all markets worldwide, a major blow to its $5.4 billion acquisition the New York pharma made two years ago.

Marketing 135

Marketing Drugs 135

World of DTC Marketing

APRIL 20, 2022

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. This was especially true with new drugs that have a significant competitive market. Will they transform their HCP marketing or stick to dated models?

Marketing 218

Marketing Drugs Drug Trials Sales 218

Pharmaceutical Technology

SEPTEMBER 1, 2023

Novo Nordisk's obesity drugs are driving Danish growth as well as record profits as the company becomes second-most valuable in Europe.

Drugs 264

Drugs Marketing 264

Pharmaceutical Technology

JUNE 12, 2023

Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure.

Marketing 242

Marketing Production Branding Manufacturing 242

Fierce Pharma

APRIL 4, 2024

Amylyx Pharmaceuticals is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial. Amylyx is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial.

Marketing 118

Marketing Drugs Trials 118

Pharmaceutical Technology

NOVEMBER 14, 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Oncopeptides’ Pepaxti (melphalan flufenamide; melflufen) along with dexamethasone to treat multiple myeloma patients. Currently, the company is analysing Pepaxti’s market access options in the country.

Marketing 130

Marketing Drugs Clinical Trials Clinical Trials 130

World of DTC Marketing

JANUARY 12, 2022

The word influencer was added to the Merriam-Webster dictionary in 2019, but influencer marketing is nothing new. Scandals, fake followers, bot technologies, and the pandemic crisis converged have put a halt to influencer marketing growth and tarnished the public view of influencers as a whole. bil­lion in 2021.

Marketing 192

Marketing Branding Production Drugs 192

Bio Pharma Dive

OCTOBER 6, 2022

The pharma will invest in the biotech and co-promote its drug teplizumab if the FDA OKs the medicine as a first-of-its-kind diabetes treatment.

Drugs 277

Drugs Marketing Medicine 277

World of DTC Marketing

APRIL 22, 2021

QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. I’ve spent the last six months analyzing clients’ DTC marketing campaigns and they are, for most ineffective. One of the most underused tactics is your product website.

Marketing 265

Marketing Doctors Doctor Production 265

Fierce Pharma

APRIL 23, 2024

The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. | The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales.

Marketing 116

Marketing Sales Drugs 116

Bio Pharma Dive

NOVEMBER 27, 2023

drugmaker withdrew the multiple myeloma drug from the U.S. market because of negative data, new study results might crack open the door to a relaunch. One year after the U.K.

Drugs 277

Drugs Trials Marketing 277

Pharmaceutical Technology

FEBRUARY 23, 2024

The FDA Office of Generic Drugs reported a rise in generic drug approvals, as several first-time generics entered the market.

Generic Drugs 263

Generic Drugs Drugs Marketing 263

Bio Pharma Dive

JANUARY 19, 2022

Study results show EQRx's drug, which it means to position as a lower-cost alternative to widely used cancer immunotherapies, extended the lives of lung cancer patients. But it's unclear whether that will be enough to sway the FDA.

Drugs 294

Drugs Marketing 294

World of DTC Marketing

MAY 17, 2022

Communication and transparency are vital to building trust, which necessitates a shift away from traditional DTC marketing. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. Some believe that these behaviors won’t translate to prescription drugs, but that would be a mistake.

Marketing 214

Marketing Pharma Companies Branding Drugs 214

World of DTC Marketing

APRIL 21, 2022

I can get better results using digital laser targeting and targeted print ads, but DTC marketers are like TV because it makes them feel important within their company. ” Marketers were tapped to develop a model that showed the patient’s journey to getting an Rx. The post DTC marketers addicted to TV.

Marketing 227

Marketing Branding Drugs Development 227

World of DTC Marketing

JANUARY 26, 2022

This is an exciting time to be in healthcare marketing. We’re witnessing the most significant transformation in healthcare marketing since DTC was approved in the ’90s. is no more an option but the critical factor to ensure success for any multichannel marketing initiatives. What about telehealth?

Marketing 202

Marketing Pharma Companies Production Drugs 202

Pharmaceutical Technology

APRIL 5, 2024

Last month, Amylyx announced that the Phase III confirmatory trial of ALS drug Relyvrio failed to meet its primary and secondary endpoints.

Drugs 130

Drugs Marketing Trials 130

pharmaphorum

OCTOBER 15, 2024

Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema

Marketing 100

Marketing Drugs 100